Investors

Stock Info
OTCQBWIZP
News
Sep 9, 2019

Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, today announced it has entered into an Exclusive License Agreement with...

Jul 8, 2019

Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that it has retained Lighthouse BioPartners, LLC a...

Jun 28, 2019

Wize Pharma, Inc. (OTCQB: WIZP) a clinical-stage biopharmaceutical company focused on the treatment of ophthalmic disorders, announced today that the Company and Cannabics Pharmaceuticals (OTCQB:...

More News

SEC Filings
0001218683
Investor Presentation
Planned Move Into Non-Viral Gene Therapy

Subscribe For Alerts
* Required Fields